Renaissance Technologies’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$84.9K Sell
12,549
-2,600
-17% -$25K ﹤0.01% 3032
2026
Q2
$164K Buy
+15,149
New +$113K ﹤0.01% 2920
2025
Q2
– Sell
-8,117
Closed -$66.6K – 3809
2025
Q1
$66.6K Buy
8,117
+2,953
+57% +$29.1K ﹤0.01% 3253
2024
Q4
$58.1K Sell
5,164
-4,526
-47% -$67.1K ﹤0.01% 3366
2024
Q3
$187K Buy
9,690
+7,454
+333% +$195K ﹤0.01% 3142
2024
Q2
$50.3K Buy
2,236
+1,460
+188% +$43.6K ﹤0.01% 3289
2024
Q1
$40K Sell
776
-2,264
-74% -$126K ﹤0.01% 3513
2023
Q4
$214K Sell
3,040
-4,216
-58% -$291K ﹤0.01% 3112
2023
Q3
$533K Buy
7,256
+5,925
+445% +$615K ﹤0.01% 2679
2023
Q2
$199K Buy
+1,331
New +$184K ﹤0.01% 3306

Other funds holding PIII

Renaissance Technologies's PIII Position: Q3 2026 in Review

Renaissance Technologies reduced its P3 Health Partners (PIII) stake by 17% in Q3 2026, selling an estimated $25K and leaving 12,549 shares worth $84.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3032.

Renaissance Technologies first reported a position in PIII in Q2 2023 and has held it in 10 quarters since. The position peaked at $533K in Q3 2023. 17 funds tracked by Wall St. Rank hold PIII as of Q3 2026.

  • Renaissance Technologies held 12,549 shares of P3 Health Partners worth $84.9K as of Q3 2026.
  • Renaissance Technologies sold 2,600 P3 Health Partners shares in Q3 2026, an estimated $25K.
  • P3 Health Partners made up ﹤0.01% of Renaissance Technologies's portfolio in Q3 2026, its #3032 holding.
  • Renaissance Technologies first reported a position in P3 Health Partners in Q2 2023 and has held it in 10 quarters since.
  • Renaissance Technologies's P3 Health Partners position peaked at $533K in Q3 2023.
  • 17 funds tracked by Wall St. Rank held P3 Health Partners as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.